This narrative review explores the relationship between mitochondrial biology and immune system activity in patients with breast cancer. Because the study was not a clinical trial, no specific patient numbers or treatment outcomes were reported. Instead, the authors discuss how these biological processes might influence disease behavior.
The review highlights several important uncertainties. Metabolic differences between patients, the body's ability to adapt to stress, and the specific roles of different immune cells are not yet fully understood. Additionally, there are currently insufficient biomarkers to accurately measure these interactions in a clinical setting.
Readers should understand that mitochondria represent a context-dependent therapeutic axis in breast cancer. This means their role can vary significantly depending on the specific situation. While this area of biology is scientifically interesting, the evidence is not yet ready to change standard medical practice. Patients should rely on established treatments while researchers continue to investigate these complex biological links.